The NKG2D receptor is expressed on the surface on NK cells, NKT cells, γδ T cells, and CD8+ cells and directly interacts with the NKG2DL ligand, whose expression is elevated on the glioma cell surface [190]. This evidence concerns the gene CD8A and glioma.